financetom
Business
financetom
/
Business
/
These 3 Samsung smartphones to cost Rs 500 more; check details here
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
These 3 Samsung smartphones to cost Rs 500 more; check details here
Jul 9, 2021 11:38 AM

Samsung has hiked the prices of three of its smartphones that belong to the M, F and A series. Under these series, the Galaxy A12, Galaxy M02s and Galaxy F02 prices have been increased by a maximum of Rs 500.

The Samsung website along with major online retailers like Flipkart and Amazon have increased the price with immediate effect.

The Samsung Galaxy A12 (4GB+64GB) model is now priced at Rs 13,499 whereas the 4GB+128GB model costs Rs 14,499. The Galaxy M02s was launched in January this year while the Galaxy A12 model was released in February. The Galaxy F02 series was launched in April, 2021.

Samsung joins other smartphone manufacturers such as Xiaomi and Oppo to increase prices in the budget or base variant segment. According to Gadgets Now, a Xiamoi spokesperson said, the past year has witnessed shortages across the supply chain leading to a demand supply mismatch. This has resulted in an upward movement in component prices used in smartphones, smart televisions, and other electronic gadgets.

Last week, smartphone manufacturer Oppo had increased its prices across five models. The Oppo A11k model saw a hike of Rs 500 and is currently selling at Rs 8,990. The Oppo A15 price too was increased by Rs 500 bringing it up to Rs 9,490. The Oppo A15s is now selling at Rs 12,490 while the Oppo A53 saw an increase of Rs 1,000 along with Oppo F19.

Xiaomi’s Redmi 9 Pro Max (4GB +64GB) was hiked by Rs 1,000 and the 4GB+128GB saw an addition of Rs 2,000. The Redmi 9 Pro Max 6GB+64GB costs Rs 2,000 more and the 6GB+128GB variant is pricier by Rs 1,000.

(Edited by : Shoma Bhattacharjee)

First Published:Jul 9, 2021 8:38 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MedX Health Raises $528,000 in Initial Closing of $2.5 Million Private Placement
MedX Health Raises $528,000 in Initial Closing of $2.5 Million Private Placement
Oct 6, 2025
08:56 AM EDT, 10/06/2025 (MT Newswires) -- MedX Health ( MDXHF ) over the weekend said it completed the initial closing of the non-brokered private placement to accredited investors, raising cash proceeds of $527,500. The initial closing included the issuance of around 7.03 million units. Under the non-brokered private placement, the company plans to issue up to a maximum of...
High Flood and Hurricane Scores Seen For Municipal Bond Offerings This Week
High Flood and Hurricane Scores Seen For Municipal Bond Offerings This Week
Oct 6, 2025
08:56 AM EDT, 10/06/2025 (MT Newswires) -- Multiple municipal bond offerings this week have a high exposure to climate risk, specifically high Flood and Hurricane Scores, according to ICE Climate Data. A $12 million offering from Center Moriches Union Free School District, N.Y., records a Flood Score of 4.8 out of 5.0, ICE reports. Locations with a component Physical Climate...
Spruce Biosciences Says FDA Grants Breakthrough Therapy Designation for Tralesinidase Alfa in Sanfilippo Syndrome
Spruce Biosciences Says FDA Grants Breakthrough Therapy Designation for Tralesinidase Alfa in Sanfilippo Syndrome
Oct 6, 2025
08:57 AM EDT, 10/06/2025 (MT Newswires) -- Spruce Biosciences ( SPRB ) said Monday that its tralesinidase alfa enzyme replacement therapy, or TA-ERT, has been granted Breakthrough Therapy Designation by the US Food and Drug Administration for the treatment of Sanfilippo Syndrome Type B. The FDA's decision was supported by long-term clinical data showing normalization of heparan sulfate non-reducing ends...
Sector Update: Consumer
Sector Update: Consumer
Oct 6, 2025
08:56 AM EDT, 10/06/2025 (MT Newswires) -- Consumer stocks were mixed premarket Monday, with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) 0.6% higher. Toyota Motor ( TM ) Chairman Akio Toyoda's proposal to buy out Toyota Industries has been delayed amid a longer-than-expected approval process under antitrust laws...
Copyright 2023-2026 - www.financetom.com All Rights Reserved